rs147916609
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000359.3(TGM1):c.401A>T(p.Tyr134Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000359.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.401A>T | p.Tyr134Phe | missense_variant | Exon 3 of 15 | 1 | NM_000359.3 | ENSP00000206765.6 | ||
TGM1 | ENST00000558074.1 | c.401A>T | p.Tyr134Phe | missense_variant | Exon 4 of 4 | 5 | ENSP00000453840.1 | |||
TGM1 | ENST00000544573.5 | c.-29+325A>T | intron_variant | Intron 2 of 8 | 2 | ENSP00000439446.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: TGM1 c.401A>T (p.Tyr134Phe) results in a conservative amino acid change located in the Transglutaminase-like domain (IPR002931) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 251446 control chromosomes. To our knowledge, no occurrence of c.401A>T in individuals affected with Lamellar Ichthyosis and no experimental evidence demonstrating its impact on protein function have been reported. Different amino acids affecting the same codon (c.401A>G, p.Y134C and c.400T>C, p.Y134H) have been classified as Pathogenic in ClinVar supporting a critical relevance of this residue to TGM1 protein function. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at